Technical Analysis for XPH - SPDR S&P Pharmaceuticals ETF
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 45.51 | 0.60% | 0.27 |
XPH closed up 0.6 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Bullish Engulfing | Bullish | 0.60% | |
Outside Day | Range Expansion | 0.60% | |
Gapped Down | Weakness | 0.60% | |
Lower Bollinger Band Touch | Weakness | 0.60% | |
Oversold Stochastic | Weakness | 0.60% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 17 hours ago |
50 DMA Resistance | about 18 hours ago |
Possible NR7 | about 18 hours ago |
1.5x Volume Pace | about 21 hours ago |
60 Minute Opening Range Breakout | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
Classification
Keywords: Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 48.76 |
52 Week Low | 35.8866 |
Average Volume | 60,075 |
200-Day Moving Average | 42.58 |
50-Day Moving Average | 45.45 |
20-Day Moving Average | 46.40 |
10-Day Moving Average | 46.55 |
Average True Range | 0.72 |
RSI (14) | 45.65 |
ADX | 19.78 |
+DI | 24.00 |
-DI | 39.39 |
Chandelier Exit (Long, 3 ATRs) | 46.62 |
Chandelier Exit (Short, 3 ATRs) | 46.54 |
Upper Bollinger Bands | 48.29 |
Lower Bollinger Band | 44.51 |
Percent B (%b) | 0.26 |
BandWidth | 8.14 |
MACD Line | 0.02 |
MACD Signal Line | 0.33 |
MACD Histogram | -0.308 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 46.04 | ||||
Resistance 3 (R3) | 45.99 | 45.76 | 45.95 | ||
Resistance 2 (R2) | 45.76 | 45.63 | 45.79 | 45.92 | |
Resistance 1 (R1) | 45.64 | 45.55 | 45.70 | 45.69 | 45.89 |
Pivot Point | 45.41 | 45.41 | 45.45 | 45.44 | 45.41 |
Support 1 (S1) | 45.29 | 45.28 | 45.35 | 45.34 | 45.13 |
Support 2 (S2) | 45.06 | 45.20 | 45.09 | 45.10 | |
Support 3 (S3) | 44.94 | 45.06 | 45.07 | ||
Support 4 (S4) | 44.99 |